Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Patrick Reynolds
The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Corrigendum: Transcriptomic Profiling of 39 Commonly-Used Neuroblastoma Cell Lines
Scientific data
Statistics
Probability
Information Sciences
Uncertainty
Library
Information Systems
Computer Science Applications
Education
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931
Frontiers in Immunology
Allergy
Immunology
P450 Inhibitor Ketoconazole Increased the Intratumor Drug Levels and Antitumor Activity of Fenretinide in Human Neuroblastoma Xenograft Models
International Journal of Cancer
Cancer Research
Oncology
Initial Testing (Stage 1) of the Polyamine Analog PG11047 by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Initial Testing of the MDM2 Inhibitor RG7112 by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Initial Testing of a Monoclonal Antibody (IMC-A12) Against IGF-1R by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Spotlight on Dinutuximab in the Treatment of High-Risk Neuroblastoma: Development and Place in Therapy
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Phase I Dose Escalation of Iodine-131–Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Initial Testing (Stage 1) of Vorinostat (SAHA) by the Pediatric Preclinical Testing Program
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
1
2
›